Literature DB >> 22257502

Comparison of phosphorylated TDP-43-positive inclusions in oculomotor neurons in patients with non-ALS and ALS disorders.

Yuji Mizuno1, Yukio Fujita, Masamitsu Takatama, Koichi Okamoto.   

Abstract

TDP-43 has been identified as a major component of the pathological inclusions in most forms of frontotemporal lobar degeneration with ubiquitin-positive inclusions and in amyotrophic lateral sclerosis (ALS). In the present study, paraffin sections of the midbrain in 112 patients with various non-ALS disorders and 27 patients with sporadic ALS were immunostained with antibody against phosphorylated TDP-43 (pTDP-43). pTDP-43-positive inclusions in oculomotor neurons were detected in 18 of 112 patients with non-ALS disorders (16.1%). The appearance of the inclusions showed fine filamentous structures rather than the skein-like inclusions seen in the anterior horn cells of ALS spinal cords. The incidence was increased in the age range of 80-89 years old (10/37 cases; 27.0%), in which 6 of 10 cases demonstrated AD pathology in the temporal lobes. Twenty-seven ALS patients were examined and the findings were compared with those of non-ALS patients. There were 13 cases demonstrating pTDP-43-positive inclusions (48.1%) which showed stronger immunoreactivities in ALS cases. This is the first report demonstrating fine filamentous pTDP-43-positive inclusions in oculomotor neurons in non-ALS disorders. Although the mechanisms underlying pTDP-43 in oculomotor neurons are currently unknown, its detection is of interest, and the expression may occur not only in ALS but also during the aging process.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257502     DOI: 10.1016/j.jns.2011.12.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.

Authors:  Michael P Hart; Johannes Brettschneider; Virginia M Y Lee; John Q Trojanowski; Aaron D Gitler
Journal:  Acta Neuropathol       Date:  2012-04-21       Impact factor: 17.088

2.  TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord.

Authors:  Johannes Brettschneider; Kimihito Arai; Kelly Del Tredici; Jon B Toledo; John L Robinson; Edward B Lee; Satoshi Kuwabara; Kazumoto Shibuya; David J Irwin; Lubin Fang; Vivianna M Van Deerlin; Lauren Elman; Leo McCluskey; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-06-12       Impact factor: 17.088

Review 3.  Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.

Authors:  Jik Nijssen; Laura H Comley; Eva Hedlund
Journal:  Acta Neuropathol       Date:  2017-04-13       Impact factor: 17.088

Review 4.  Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.

Authors:  Yuichi Riku; Danielle Seilhean; Charles Duyckaerts; Susana Boluda; Yohei Iguchi; Shinsuke Ishigaki; Yasushi Iwasaki; Mari Yoshida; Gen Sobue; Masahisa Katsuno
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 5.  The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis.

Authors:  Christoph Schweingruber; Eva Hedlund
Journal:  Biology (Basel)       Date:  2022-08-08

6.  Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks.

Authors:  Malcolm Proudfoot; Ricarda A L Menke; Rakesh Sharma; Claire M Berna; Stephen L Hicks; Christopher Kennard; Kevin Talbot; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-27       Impact factor: 4.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.